University of Otago.Department of Physiology.Department of Physiology.

Physiology TV

An overview of Physiology at the University of Otago.

News

8th September, 2017

PhD student wins two awards at Queenstown Research Week

Congratulations to Mauro Silva, PhD student in the Department of Physiology. Mauro is supervised by Dr Rebecca Campbell.

8th September, 2017

Triennial Medal awarded to Professor Colin Brown

Congratulations to Colin who as been chosen by the Physiological Society of NZ (PSNZ) to be the recipient of the NZ Triennial Medal.

28th August, 2017

Dr Andrew Bahn awarded Arthritis NZ Project Grant

Congratulations to Dr Bahn who has been awarded a $60K grant for his project “Identification of oxypurinol transporters to decipher drug-drug interactions in gout treatment”.

25th August, 2017

Congratulations to Lorna Daniels, PhD

Lorna Daniels’ PhD thesis has made the Health Sciences Divisional List of Exceptional Doctoral theses.

14th August, 2017

Professor Colin Brown recognised by the British Society for Neuroendocrinology (BSN)

Prof Brown has been awarded the 2017 Mortyn Jones Memorial Medal, which is awarded annually by the BSN.

Next Event

25th September, 2017

Professor John Evans (Department of Obstetrics and Gynaecology, University of Otago Christchurch)

 
PhD Programme.

News

28th August, 2017

Dr Andrew Bahn awarded Arthritis NZ Project Grant

Dr Andrew Bahn awarded Arthritis NZ Project Grant

Congratulations to Dr Bahn who has been awarded a $60K grant for his project “Identification of oxypurinol transporters to decipher drug-drug interactions in gout treatment”.

Gout is a painful inflammation of the joins due to high serum uric acid (SUA) based mostly on an unhealthy Western diet. The gold standard for gout treatment is allopurinol. Once converted into oxypurinol, it inhibits production of uric acid in the liver and lowers SUA. Gout has been associated with many comorbidities including hypertension, which requires adjustment of allopurinol dosage. These drug-drug interactions render gout treatment with allopurinol ineffective exposing the patient to further gout attacks and the risk of life threatening side effects. As drug-drug interactions are based on competition of drugs at transport proteins we hypothesise transporters of the organic anion transporter family (OATs), which are expressed in liver and kidney, are responsible for the observed drug-drug interaction. By investigating these drug-drug interactions in primary human kidney and liver cells, Dr Bahn aims to identify allopurinol/oxypurinol transporters to resolve these drug-drug interactions and improve management of gout treatment.

It's fun getting your hands into the job, e.g. doing experiments on a beating heart. Suddenly all those theories you have been learning about, are made real!

Juliet Kane - BSc (Physiology) student